Partnering & Licensing
Myriad Genetics develops and markets molecular diagnostic products in the areas of predictive medicine, personalized medicine, and prognostic medicine.
We have a strong commitment to being a leader in the molecular diagnostic field and understanding the value of building strong partnerships with other companies and laboratories to accomplish this strategic goal. We have a proven track record for building strong, collaborative relationships with cancer treatment centers of excellence and world renowned institutions with the mutual goal of enhancing and individualizing care.
Myriad welcomes the chance to review details of a prospective, mutual opportunity within our general areas of interest. Please contact us for more information about the business development opportunities described within our company website, questions you may have concerning a possible fit of your opportunity with Myriad's interests, or to schedule an initial phone call discussion.
To assist initiation of our diligence, please send us non-confidential information concerning your technology or product, complete contact information so that we can respond properly and an overview summary about your institution.
The Myriad Business Development teams look forward to hearing from you.
For business opportunities that involve technologies in the early or middle stages of research and development, such as technologies commonly found within universities, hospitals, and startup companies, please contact:
John Gill, JD, MBA
Senior Director, Business Development
Myriad Genetics, Inc.
jgill@myriad.com
(801) 746-6513
For business opportunities that involve technologies in the late stage of research and development or that involve products ready-for-market, please contact:
Mike Hansen, PhD, MBA
VP, Business Development
Myriad Genetic Laboratories, Inc.
mihansen@myriad.com
(801) 505-5065
If unsure about whom to contact at Myriad business development concerning your opportunity, please copy both John and Mike on your correspondence.
